| Year |
Citation |
Score |
| 2023 |
Jin WJ, Zangl LM, Hyun M, Massoud E, Schroeder K, Alexandridis RA, Morris ZS. ATM inhibition augments type I interferon response and antitumor T-cell immunity when combined with radiation therapy in murine tumor models. Journal For Immunotherapy of Cancer. 11. PMID 37730275 DOI: 10.1136/jitc-2023-007474 |
0.302 |
|
| 2023 |
O'Leary KA, Bates AM, Jin WJ, Burkel BM, Sriramaneni RN, Emma SE, Nystuen EJ, Sumiec EG, Ponik SM, Morris ZS, Schuler LA. Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy. Breast Cancer Research : Bcr. 25: 68. PMID 37312163 DOI: 10.1186/s13058-023-01671-y |
0.314 |
|
| 2021 |
Li M, Liu D, Lee D, Cheng Y, Baumhover NJ, Marks BM, Sagastume EA, Ballas ZK, Johnson FL, Morris ZS, Schultz MK. Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma. Cancers. 13. PMID 34359580 DOI: 10.3390/cancers13153676 |
0.321 |
|
| 2021 |
Patel RB, Hernandez R, Carlson P, Grudzinski J, Bates AM, Jagodinsky JC, Erbe A, Marsh IR, Arthur I, Aluicio-Sarduy E, Sriramaneni RN, Jin WJ, Massey C, Rakhmilevich AL, Vail D, ... ... Morris ZS, et al. Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade. Science Translational Medicine. 13. PMID 34261797 DOI: 10.1126/scitranslmed.abb3631 |
0.331 |
|
| 2021 |
Onate AJ, Clark PA, Morris ZS. Using Radiation Therapy to Prime and Propagate an Anti-tumor Immune Response Against Brain Tumors. Neuromolecular Medicine. PMID 34081276 DOI: 10.1007/s12017-021-08668-w |
0.322 |
|
| 2021 |
Bates AM, Brown RJ, Pieper AA, Zangl LM, Arthur I, Carlson PM, Le T, Sosa GA, Clark PA, Sriramaneni RN, Kim K, Patel RB, Morris ZS. Combination of Bempegaldesleukin and Anti-CTLA-4 Prevents Metastatic Dissemination After Primary Resection or Radiotherapy in a Preclinical Model of Non-Small Cell Lung Cancer. Frontiers in Oncology. 11: 645352. PMID 33937052 DOI: 10.3389/fonc.2021.645352 |
0.321 |
|
| 2020 |
Jin WJ, Erbe AK, Schwarz CN, Jaquish AA, Anderson BR, Sriramaneni RN, Jagodinsky JC, Bates AM, Clark PA, Le T, Lan KH, Chen Y, Kim K, Morris ZS. Tumor-Specific Antibody, Cetuximab, Enhances the Vaccine Effect of Radiation in Immunologically Cold Head and Neck Squamous Cell Carcinoma. Frontiers in Immunology. 11: 591139. PMID 33281820 DOI: 10.3389/fimmu.2020.591139 |
0.36 |
|
| 2020 |
Baniel CC, Heinze CM, Hoefges A, Sumiec EG, Hank JA, Carlson PM, Jin WJ, Patel RB, Sriramaneni RN, Gillies SD, Erbe AK, Schwarz CN, Pieper AA, Rakhmilevich AL, Sondel PM, ... Morris ZS, et al. Vaccine Plus Checkpoint Blockade Induces Memory Humoral Response. Frontiers in Immunology. 11: 1610. PMID 32849544 DOI: 10.3389/Fimmu.2020.01610 |
0.403 |
|
| 2020 |
Clark PA, Sriramaneni RN, Jin WJ, Jagodinsky JC, Bates AM, Jaquish AA, Anderson BR, Le T, Lubin JA, Chakravarty I, Arthur IS, Heinze CM, Guy EI, Kler J, Klar KA, ... ... Morris ZS, et al. In situ vaccination at a peripheral tumor site augments response against melanoma brain metastases. Journal For Immunotherapy of Cancer. 8. PMID 32690669 DOI: 10.1136/Jitc-2020-000809 |
0.335 |
|
| 2020 |
Jagodinsky JC, Morris ZS. Priming and Propagating Anti-tumor Immunity: Focal Hypofractionated Radiation for in Situ Vaccination and Systemic Targeted Radionuclide Theranostics for Immunomodulation of Tumor Microenvironments. Seminars in Radiation Oncology. 30: 181-186. PMID 32381297 DOI: 10.1016/J.Semradonc.2019.12.008 |
0.396 |
|
| 2020 |
Jagodinsky JC, Harari PM, Morris ZS. The Promise of Combining Radiation Therapy with Immunotherapy. International Journal of Radiation Oncology, Biology, Physics. PMID 32335187 DOI: 10.1016/J.Ijrobp.2020.04.023 |
0.392 |
|
| 2020 |
Yang RK, Kuznetsov IB, Ranheim EA, Wei JS, Sindiri S, Gryder BE, Gangalapudi V, Song YK, Patel V, Hank JA, Zuleger CL, Erbe AK, Morris ZS, Quale R, Kim K, et al. Outcome-related signatures identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated After Starting Hu14.18-IL2. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32152202 DOI: 10.1158/1078-0432.Ccr-19-3294 |
0.311 |
|
| 2020 |
Sosa GA, Bates AM, Patel R, Hernandez R, Grudzinski JJ, Marsh I, Bednarz B, Pieper A, Nystuen E, Emma S, Sumiec EG, Weichert JP, Morris ZS. Abstract 903: In vivo efficacy of bempegaldesleukin, immune checkpoint inhibition, and targeted radionuclide therapy in immunocompetent murine model of head and neck cancer Immunology. 80: 903-903. DOI: 10.1158/1538-7445.Am2020-903 |
0.414 |
|
| 2020 |
Sumiec EG, Baniel CC, Bates AM, Emma S, Nystuen E, Rakhmilevich AL, Erbe AK, Paul P, Galipeau J, Sondel PM, Morris ZS. Abstract 902: Augmentation of anti-melanoma response by combining radiation-based in situ vaccination with GIFT4 B cell therapy Immunology. 80: 902-902. DOI: 10.1158/1538-7445.Am2020-902 |
0.389 |
|
| 2020 |
Jagodinsky JC, Arthur IS, Castillo JS, Chakravarty I, Zangl LM, Brown RJ, Patel RB, Jin WJ, Carlson PM, Hernandez R, Grudzinski JJ, Marsh IR, Weichert JP, Bednarz BP, Morris ZS. Abstract 477: Comparing type 1 interferon activation in tumor cells following external beam radiotherapy versus targeted radionuclide therapy Tumor Biology. DOI: 10.1158/1538-7445.Am2020-477 |
0.36 |
|
| 2020 |
Clark PA, Sriramaneni RN, Pieper A, Bates AM, Anderson BR, Jin W, Jagodinsky JC, Rakhmilevich AL, Morris ZS. Abstract 4440: Bempegaldesleukin (NKTR-214), a CD122 preferential IL-2 pathway agonist, augments the in situ vaccine response to radiation of an extracranial tumor in a murine melanoma model, conferring response at non-radiated tumor sites in the brain Immunology. 80: 4440-4440. DOI: 10.1158/1538-7445.Am2020-4440 |
0.428 |
|
| 2020 |
Jin W, Erbe AK, Schwarz C, Jaquish A, Anderson BR, Sriramaneni RN, Jagodinsky JC, Clark PA, Morris ZS. Abstract 1881: Immune mediated interaction between radiation and cetuximab in a syngeneic murine model of head and neck squamous cell carcinoma Cancer Research. 80: 1881-1881. DOI: 10.1158/1538-7445.Am2020-1881 |
0.427 |
|
| 2019 |
Voeller J, Erbe AK, Slowinski J, Rasmussen K, Carlson PM, Hoefges A, VandenHeuvel S, Stuckwisch A, Wang X, Gillies SD, Patel RB, Farrel A, Rokita JL, Maris J, Hank JA, ... Morris ZS, et al. Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition. Journal For Immunotherapy of Cancer. 7: 344. PMID 31810498 DOI: 10.1186/S40425-019-0823-6 |
0.403 |
|
| 2019 |
Patel RB, Ye M, Carlson PM, Jaquish A, Zangl L, Ma B, Wang Y, Arthur I, Xie R, Brown RJ, Wang X, Sriramaneni R, Kim K, Gong S, Morris ZS. Development of an In Situ Cancer Vaccine via Combinational Radiation and Bacterial-Membrane-Coated Nanoparticles. Advanced Materials (Deerfield Beach, Fla.). e1902626. PMID 31523868 DOI: 10.1002/Adma.201902626 |
0.424 |
|
| 2019 |
Grudzinski JJ, Hernandez R, Marsh I, Patel R, Aluicio-Sarduy E, Engle J, Morris Z, Bednarz B, Weichert JP. Preclinical Characterization of Y-NM600 in a variety of murine and human cancer tumor models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30954941 DOI: 10.2967/Jnumed.118.224808 |
0.378 |
|
| 2019 |
Lee A, Kuczmarska-Haas A, Macomber MW, Woo K, Freese C, Morris ZS. International Survey on the Use of Complementary and Alternative Medicines for Common Toxicities of Radiation Therapy. Advances in Radiation Oncology. 4: 134-141. PMID 30706021 DOI: 10.1016/J.Ijrobp.2018.07.1958 |
0.311 |
|
| 2019 |
Zangl L, Pieper A, Arthur I, Brown R, Rakhmilevich A, Sondel P, Morris Z, Patel R. External Beam Radiotherapy Required for Tumor Regression When Using CpG-Oligodeoxynucleotide and Anti-OX40 in an Immunologically Cold Tumor Model International Journal of Radiation Oncology*Biology*Physics. 105: S88. DOI: 10.1016/J.Ijrobp.2019.06.560 |
0.356 |
|
| 2018 |
Chiasson-MacKenzie C, Morris ZS, Liu CH, Bradford WB, Koorman T, McClatchey AI. Merlin/ERM proteins regulate growth factor-induced macropinocytosis and receptor recycling by organizing the plasma membrane:cytoskeleton interface. Genes & Development. PMID 30143526 DOI: 10.1101/Gad.317354.118 |
0.594 |
|
| 2018 |
Patel RB, Baniel CC, Sriramaneni RN, Bradley K, Markovina S, Morris ZS. Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities. Brachytherapy. PMID 30078541 DOI: 10.1016/J.Brachy.2018.07.004 |
0.447 |
|
| 2018 |
Morris ZS, Guy EI, Werner LR, Carlson PM, Heinze CM, Kler JS, Busche SM, Jaquish AA, Sriramaneni RN, Carmichael L, Loibner H, Gillies SD, Korman AJ, Erbe AK, Hank JA, et al. Tumor-specific inhibition of in situ vaccination by distant untreated tumor sites. Cancer Immunology Research. PMID 29748391 DOI: 10.1158/2326-6066.Cir-17-0353 |
0.406 |
|
| 2018 |
Bristow RG, Alexander B, Baumann M, Bratman SV, Brown JM, Camphausen K, Choyke P, Citrin D, Contessa JN, Dicker A, Kirsch DG, Krause M, Le QT, Milosevic M, Morris ZS, et al. Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology. The Lancet. Oncology. 19: e240-e251. PMID 29726389 DOI: 10.1016/S1470-2045(18)30096-2 |
0.344 |
|
| 2018 |
Patel R, Hernandez R, Brown R, Grudzinski J, Carlson P, Sriramaneni R, Bednarz B, Sondel P, Weichert J, Morris Z. Systemic Administration of Molecularly Targeted Radiation Therapy (MTRT) Improves the Efficacy of anti-CTLA-4 in a Murine B78 Melanoma Model International Journal of Radiation Oncology*Biology*Physics. 102: S154. DOI: 10.1016/J.Ijrobp.2018.06.372 |
0.314 |
|
| 2017 |
Werner LR, Kler JS, Gressett MM, Riegert M, Werner LK, Heinze CM, Kern JG, Abbariki M, Erbe AK, Patel RB, Sriramaneni RN, Harari PM, Morris ZS. Transcriptional-mediated effects of radiation on the expression of immune susceptibility markers in melanoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28893414 DOI: 10.1016/J.Radonc.2017.08.016 |
0.385 |
|
| 2017 |
Baniel C, Hank JA, Guy EI, Gillies SD, Korman AJ, Loibner H, Rakhmilevich AL, Harari PM, Sondel PM, Morris ZS. In situ vaccination with local radiation and intratumoral immunocytokine to elicit a tumor-specific memory B-cell response. Journal of Clinical Oncology. 35: 69-69. DOI: 10.1200/Jco.2017.35.7_Suppl.69 |
0.373 |
|
| 2017 |
Morris BA, Bayliss RAB, Anger N, Morris ZS, Ritter MA. A Phase 1/2 Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With a Simultaneous Integrated Boost to MRI-Identified Regions of High Tumor Volume (NCT02470897) International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1213 |
0.339 |
|
| 2016 |
Morris ZS, Saha S, Magnuson WJ, Morris BA, Borkenhagen JF, Ching A, Hirose G, McMurry V, Francis DM, Harari PM, Chappell R, Tsuji S, Ritter MA. Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Cancer. PMID 27203227 DOI: 10.1002/Cncr.30079 |
0.356 |
|
| 2016 |
Morris ZS, Guy EI, Francis DM, Gressett MM, Werner LR, Carmichael L, Yang RK, Armstrong EA, Huang S, Navid F, Gillies SD, Korman AJ, Hank JA, Rakhmilevich AL, Harari PM, et al. In situ tumor vaccination by combining local radiation and tumor-specific antibody or immunocytokine treatments. Cancer Research. PMID 27197149 DOI: 10.1158/0008-5472.Can-15-2644 |
0.448 |
|
| 2016 |
Werner LR, Gressett M, Riegert M, Huang S, Kern JG, Erbe A, Harari PM, Sondel PM, Morris ZS. Abstract 4013: Transcriptionally mediated effects of radiation on the expression of immune susceptibility markers in murine and human melanoma Cancer Research. 76: 4013-4013. DOI: 10.1158/1538-7445.Am2016-4013 |
0.395 |
|
| 2016 |
Morris ZS, Guy E, Francis D, Gressett MM, Armstrong EA, Huang S, Werner LR, Gillies SD, Korman A, Hank JA, Rakhmilevich AL, Harari PM, Sondel PM. Abstract 4011: Effectivein situimmunization via local radiation therapy (RT) and tumor-specific immunocytokine (IC): Suppression from distant tumor is blocked by RT or Treg-depleting CTLA-4 antibody Cancer Research. 76: 4011-4011. DOI: 10.1158/1538-7445.Am2016-4011 |
0.396 |
|
| 2015 |
Chiasson-MacKenzie C, Morris ZS, Baca Q, Morris B, Coker JK, Mirchev R, Jensen AE, Carey T, Stott SL, Golan DE, McClatchey AI. NF2/Merlin mediates contact-dependent inhibition of EGFR mobility and internalization via cortical actomyosin. The Journal of Cell Biology. 211: 391-405. PMID 26483553 DOI: 10.1083/Jcb.201503081 |
0.613 |
|
| 2015 |
Francis DM, Huang S, Armstrong EA, Werner LR, Hullett CR, Li C, Morris ZS, Swick AD, Kragh M, Lantto J, Kimple RJ, Harari PM. Pan-HER receptor inhibition augments radiation response in human lung and head and neck cancer models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26420857 DOI: 10.1158/1078-0432.Ccr-15-1664 |
0.347 |
|
| 2015 |
Morris ZS, Cannon DM, Morris BA, Bentzen SM, Kozak KR. Impact of a Contralateral Tumor Nodule on Survival in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 26317917 DOI: 10.1097/Jto.0000000000000655 |
0.365 |
|
| 2015 |
Wang W, Erbe AK, Hank JA, Morris ZS, Sondel PM. NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy. Frontiers in Immunology. 6: 368. PMID 26284063 DOI: 10.3389/Fimmu.2015.00368 |
0.366 |
|
| 2015 |
Morris ZS, Weichert JP, Saker J, Armstrong EA, Besemer A, Bednarz B, Kimple RJ, Harari PM. Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 116: 504-9. PMID 26123834 DOI: 10.1016/J.Radonc.2015.06.015 |
0.336 |
|
| 2015 |
Morris ZS, Guy EI, Francis DM, Gressett MM, Armstrong EA, Huang S, Gillies SD, Korman AJ, Hank JA, Rakhmilevich AL, Harari PM, Sondel PM. Immunocytokine augments local and abscopal response and animal survival when added to radiation and CTLA-4 checkpoint inhibition in a murine melanoma model Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P308 |
0.429 |
|
| 2015 |
Morris Z, Guy E, Francis D, Gressett M, Armstrong E, Huang S, Gilles S, Korman A, Hank J, Rakhmilevich A, Sondel P, Harari P. Immunocytokine Augments the Local and Abscopal Response to Radiation and CTLA4 Checkpoint Inhibition in a Murine Melanoma Model International Journal of Radiation Oncology*Biology*Physics. 93: S93-S94. DOI: 10.1016/J.Ijrobp.2015.07.224 |
0.328 |
|
| 2014 |
Morris ZS, Harari PM. Interaction of radiation therapy with molecular targeted agents. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 2886-93. PMID 25113770 DOI: 10.1200/Jco.2014.55.1366 |
0.327 |
|
| 2014 |
Morris ZS, Guy E, Francis D, Gressett M, Yang R, Rakhmilevich A, Hank J, Gillies S, Harari P, Sondel P. In vivo synergy of radiation and hu14.18-IL2 immunocytokine results in a memory T cell response in a syngeneic murine melanoma model Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P160 |
0.361 |
|
| 2014 |
Magnuson WJ, Morris Z, Mohindra P, Geye H, Harari P. Potential Influence of ACE Inhibitors and Angiotensin Receptor Blockers on Outcome in Patients With Oropharynx Cancer Treated With Radiation Therapy International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1581 |
0.321 |
|
| 2014 |
Morris ZS, Magnuson WJ, Borkenhagen JF, Francis D, Harari PM, Tsuji S, Ritter MA. Increased Pathologic Complete Response to Neoadjuvant Radiation in Rectal Cancer Patients Taking an Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1264 |
0.306 |
|
| 2013 |
Morris Z, Cannon D, Bentzen S, Kozak K. Impact of Contralateral Tumor Nodules on Survival in Non-Small Cell Lung Cancer: A SEER Database Analysis International Journal of Radiation Oncology*Biology*Physics. 87: S36. DOI: 10.1016/J.Ijrobp.2013.06.095 |
0.356 |
|
| 2011 |
Lin CI, Barletta JA, Nehs MA, Morris ZS, Donner DB, Whang EE, Jeong JW, Kimura S, Moore FD, Ruan DT. Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity. Surgery. 150: 1295-302. PMID 22136853 DOI: 10.1016/J.Surg.2011.09.014 |
0.328 |
|
| 2009 |
Morris ZS, McClatchey AI. Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma. Proceedings of the National Academy of Sciences of the United States of America. 106: 9767-72. PMID 19487675 DOI: 10.1073/Pnas.0902031106 |
0.616 |
|
| 2009 |
Morris ZS, McClatchey AI. The neurofibroma cell of origin: SKPs expand the playing field. Cell Stem Cell. 4: 371-2. PMID 19427284 DOI: 10.1016/J.Stem.2009.04.010 |
0.605 |
|
| Show low-probability matches. |